KIERSTIN WEBB: Open Payments
NPI 1609424431 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 69 payments from 17 companies in 2025. Trend: 2023 $821 · 2024 $1,113 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $336 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $105 |
| Lilly USA, LLC | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $86 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 4 | $70 |
| Novo Nordisk Inc | 4 | $67 |
| Dexcom, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 5 | $51 |
Products named: JARDIANCE, Kerendia, CREON, CAPLYTA, UBRELVY, MOUNJARO, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across NC — which companies pay providers there.
